Literature DB >> 26016693

Psychotropic medicine prescriptions in Italian youths: a multiregional study.

Daniele Piovani1, Antonio Clavenna2, Massimo Cartabia2, Maurizio Bonati2.   

Abstract

The aim of the study was to evaluate the trend of paediatric psychotropic drug prescriptions in Italy. Data sources were regional, outpatient prescription databases. Seven Italian regions, covering 50 % of the Italian population, provided data from 2006 to 2011. Prevalence and incidence of prescriptions by age and gender were evaluated for psychotropic, antidepressant, antipsychotic, and attention-deficit/hyperactivity disorders (ADHD) medications. The hospital admission rate for psychiatric conditions was calculated, also at the local health unit (LHU) level. The presence of trends in prescription prevalence and incidence during the 6 year period was assessed. Finally, the correlation between prevalence, prescription, hospital admission rates, latitude, longitude, and average annual income at the LHU level was also investigated. In 2011, 8834 youths received at least one psychotropic drug prescription, with a prevalence of 1.76 ‰ (95 % CI 1.72-1.80). The incidence of new psychotropic drug users was 1.03 ‰ (1.00-1.06). The prevalence of antidepressants was 1.02 ‰ (0.99-1.04), while that of antipsychotics was 0.70 ‰ (0.68-0.72), and that of ADHD medications 0.19 ‰ (0.18-0.21). The psychotropic drug prevalence increased with increasing age. Males were more exposed to psychotropic drugs than females (AUC0-17 male/female = 1.23). Antipsychotics were the most prescribed psychotropic drugs in males, while antidepressants were in females. Between-region prevalence ranged from 1.56 to 2.17 ‰. The overall prevalence of psychotropic drug from 2006 to 2011 was stable (χ(t)2 ≤ 0.001, p = 0.97). No correlation was found between prevalence and the variables investigated. Psychotropic drug prescription was very limited and stable. No geographical patterns were found.

Entities:  

Keywords:  Adolescent; Child; Outpatients; Pharmacoepidemiology; Psychotropic drugs

Mesh:

Substances:

Year:  2015        PMID: 26016693     DOI: 10.1007/s00787-015-0726-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  54 in total

1.  Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis.

Authors:  William W Stoops; Paul E A Glaser; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2003-08-20       Impact factor: 4.492

2.  Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd; Sally K Guthrie
Journal:  J Adolesc Health       Date:  2004-12       Impact factor: 5.012

Review 3.  The epidemiology of psychotropic drug use in children and adolescents.

Authors:  M Bonati; A Clavenna
Journal:  Int Rev Psychiatry       Date:  2005-06

4.  Reducing overdiagnosis and disease mongering in ADHD in Lombardy.

Authors:  Maurizio Bonati; Laura Reale
Journal:  BMJ       Date:  2013-12-16

5.  Stimulant medication use in children: a 12-year perspective.

Authors:  Samuel H Zuvekas; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

6.  One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.

Authors:  Anna Didoni; Marco Sequi; Pietro Panei; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2011-05-03       Impact factor: 2.953

7.  Use of antipsychotic drugs among Dutch youths between 1997 and 2005.

Authors:  Luuk J Kalverdijk; Hilde Tobi; Paul B van den Berg; Janelle Buiskool; Leonie Wagenaar; Ruud B Minderaa; Lolkje T W de Jong-van den Berg
Journal:  Psychiatr Serv       Date:  2008-05       Impact factor: 3.084

8.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

9.  Trends in antidepressant prescriptions for children and adolescents in Germany from 2005 to 2012.

Authors:  Falk Hoffmann; Gerd Glaeske; Christian J Bachmann
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-05-16       Impact factor: 2.890

10.  Antidepressant and antipsychotic use in an Italian pediatric population.

Authors:  Antonio Clavenna; Margherita Andretta; Paola Pilati; Maurizio Dusi; Michele Gangemi; Maria Beatrice Gattoni; Giuseppe Lombardo; Leonardo Zoccante; Luigi Mezzalira; Maurizio Bonati
Journal:  BMC Pediatr       Date:  2011-05-23       Impact factor: 2.125

View more
  12 in total

1.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

Review 2.  The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Authors:  Gianluca Trifirò; Rosa Gini; Francesco Barone-Adesi; Ettore Beghi; Anna Cantarutti; Annalisa Capuano; Carla Carnovale; Antonio Clavenna; Mirosa Dellagiovanna; Carmen Ferrajolo; Matteo Franchi; Ylenia Ingrasciotta; Ursula Kirchmayer; Francesco Lapi; Roberto Leone; Olivia Leoni; Ersilia Lucenteforte; Ugo Moretti; Alessandro Mugelli; Luigi Naldi; Elisabetta Poluzzi; Concita Rafaniello; Federico Rea; Janet Sultana; Mauro Tettamanti; Giuseppe Traversa; Alfredo Vannacci; Lorenzo Mantovani; Giovanni Corrao
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

Review 3.  The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.

Authors:  Daria Putignano; Antonio Clavenna; Laura Reale; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

4.  Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study.

Authors:  Ainhoa Gómez-Lumbreras; Ana Garcia Sangenis; Oriol Prat Vallverdú; Anna Gatell Carbó; Cristina Vedia Urgell; Laura Gisbert Gustemps; Xavier Bruna Pérez; Antoni Ramos Quiroga; Rosa Morros Pedrós
Journal:  Psychopharmacology (Berl)       Date:  2021-03-10       Impact factor: 4.530

5.  Psychopharmacological Prescriptions in Children and Adolescents in Germany.

Authors:  Sascha Abbas; Peter Ihle; Jürgen-Bernhard Adler; Susanne Engel; Christian Günster; Roland Linder; Gerd Lehmkuhl; Ingrid Schübert
Journal:  Dtsch Arztebl Int       Date:  2016-06-06       Impact factor: 5.594

6.  Do autistic patients change healthcare services utilisation through the transition age? An Italian longitudinal retrospective study.

Authors:  Sara Tunesi; Marco Bosio; Antonio Giampiero Russo
Journal:  BMJ Open       Date:  2019-11-14       Impact factor: 2.692

7.  Prevalence, incidence and persistence of ADHD drug use in Japan.

Authors:  Y Okumura; M Usami; T Okada; T Saito; H Negoro; N Tsujii; J Fujita; J Iida
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-28       Impact factor: 6.892

Review 8.  Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists.

Authors:  Simone Pisano; Gennaro Catone; Stefania Veltri; Valentina Lanzara; Marco Pozzi; Emilio Clementi; Raffaella Iuliano; Maria Pia Riccio; Sonia Radice; Massimo Molteni; Annalisa Capuano; Antonella Gritti; Giangennaro Coppola; Annarita Milone; Carmela Bravaccio; Gabriele Masi
Journal:  Ital J Pediatr       Date:  2016-05-21       Impact factor: 2.638

9.  'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'.

Authors:  Florentia Kaguelidou; Jakob Holstiege; Tania Schink; Irene Bezemer; Elisabetta Poluzzi; Giampiero Mazzaglia; Lars Pedersen; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-20       Impact factor: 6.892

10.  New Users of Antipsychotics Among Children and Adolescents in 2008-2017: A Nationwide Register Study.

Authors:  Eveliina Varimo; Leena K Saastamoinen; Hanna Rättö; Hannu Mogk; Eeva T Aronen
Journal:  Front Psychiatry       Date:  2020-04-24       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.